Correlation Between Diamyd Medical and ENVVENO MEDICAL

Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and ENVVENO MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and ENVVENO MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diamyd Medical AB and ENVVENO MEDICAL DL 00001, you can compare the effects of market volatilities on Diamyd Medical and ENVVENO MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of ENVVENO MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and ENVVENO MEDICAL.

Diversification Opportunities for Diamyd Medical and ENVVENO MEDICAL

0.65

Correlation Coefficient

Diamyd Medical  ENVVENO MEDICAL

Poor diversification

The 3 months correlation between Diamyd and ENVVENO is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and ENVVENO MEDICAL DL 00001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENVVENO MEDICAL DL and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with ENVVENO MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENVVENO MEDICAL DL has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and ENVVENO MEDICAL go up and down completely randomly.

Pair Corralation between Diamyd Medical and ENVVENO MEDICAL

Assuming the 90 days horizon Diamyd Medical AB is expected to under-perform the ENVVENO MEDICAL. In addition to that, Diamyd Medical is 1.14 times more volatile than ENVVENO MEDICAL DL 00001. It trades about -0.15 of its total potential returns per unit of risk. ENVVENO MEDICAL DL 00001 is currently generating about 0.04 per unit of volatility. If you would invest  252.00  in ENVVENO MEDICAL DL 00001 on December 20, 2024 and sell it today you would earn a total of  12.00  from holding ENVVENO MEDICAL DL 00001 or generate 4.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Diamyd Medical AB  vs.  ENVVENO MEDICAL DL 00001

Diamyd Medical AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ENVVENO MEDICAL DL

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ENVVENO MEDICAL DL 00001 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, ENVVENO MEDICAL may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Diamyd Medical and ENVVENO MEDICAL

The main advantage of trading using opposite Diamyd Medical and ENVVENO MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, ENVVENO MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENVVENO MEDICAL will offset losses from the drop in ENVVENO MEDICAL's long position.

The idea behind Diamyd Medical AB and ENVVENO MEDICAL DL 00001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.